You browser is out of date and some functionality on this site may be not supported.
Please consider upgrading to the latest version of your browser for the best possible experience.
Kindly note that this website is not compatible with this browser. Some features may not work. Inconvenience regretted.
A versatile tool for Newborn Screening with high format flexibility and detection sensibility.
Labsystems Diagnostics NS200 is a user-friendly and affordable fluorescence reader, designed to cater to the Newborn Screening needs of today's applications. For uncompromised performance in all detection modes, the NS200 uses advanced optics and high-performance detectors. The NS200 offers versatile measuring modes and formats with exceptional sensitivity levels.
Users can select the desired features to create the perfect reader for their needs, with the option to upgrade as requirements change. The NS200 offers excellent sensitivity, multiplexing capabilities and high formate flexibility, including 6- to 384-well microplates (designed for Cell-based assays and/or high throughput library screening) and PCR plates.
The NS200 can be used for all Labsystems Diagnostics NBS applications and many other laboratory developed tests or commercial assays. NS200 can also be integrated onto NS2400 fully automatic newborn screening platform and thus makes the transition from semi-automated assay processing to fully integrated-high throughput sample analysis smoother and with lower validation requirements.
The NS200 offers a wide range of detection modes
- Fluorescence intensity (top reading)
- Fluorescence resonance energy transfer (FRET)
- Time resolved fluorescence energy transfer (TR-FRET) like HTRF
- Time resolved fluorescence (TRF)
- Incubation and shaking
- Temperature control
- Sample measurement with various plate formats
A versatile user interface and powerful data reduction capabilities enable the optimization of sophisticated experimental work as well as making routine tasks easy. As an upgrade, there is also available a highly functional analysis software, which is in compliance with FDA21 CFR part 11 and European Directive 98/79/EC (IVD-D).